A Cost Analysis of Interstim Therapy - Full Text View

Sponsored by:	MedtronicNeuro
Information provided by:	MedtronicNeuro
ClinicalTrials.gov Identifier:	NCT00200031

Purpose

A study to examine the impact that Interstim Therapy for Urinary Control has on health care utilization and costs within a health care system and the satisfaction with treatment expressed by patients using this therapy.

Condition	Intervention
Urinary Retention and Symptoms of Overactive Bladder (Urge, Frequency)	Device: Interstim therapy

U.S. FDA Resources

Study Type:	Observational
Official Title:	Interstim Therapy Retrospective Cost Analysis and Quality of Life

Further study details as provided by MedtronicNeuro:

Estimated Enrollment:	150
Study Start Date:	July 2005
Study Completion Date:	April 2006

Detailed Description:

A retrospective administrative data analysis combined with a prospective health related quality of life/satisfaction with treatment survey designed to examine the impact that Interstim Therapy for Urinary Control has had on health care utilization and costs for the Kaiser Permanente system and the satisfaction with treatment expressed by patients using this therapy.

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both

Criteria

Patients implanted with an Interstim Therapy for Urinary Control or undergoing test stimulation for potential placement of Interstim Therapy during the period of June 1, 2002 through June 30, 2004 and who are enrolled with Kaiser-Permanente of Southern California.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00200031

Locations

United States, California
Southern California Permanente Medical Group
Los Angeles, California, United States, 90027

Sponsors and Collaborators

MedtronicNeuro

Investigators

Principal Investigator:

Sherif Aboseif, MD

Kaiser Permanente

More Information

Publications of Results:

Aboseif SR, Kim DH, Rieder JM, Rhee EY, Menefee SA, Kaswick JR, Ree MH. Sacral neuromodulation: cost considerations and clinical benefits. Urology. 2007 Dec;70(6):1069-73; discussion 1073-4.

Study ID Numbers:	4348
Study First Received:	September 12, 2005
Last Updated:	July 24, 2008
ClinicalTrials.gov Identifier:	NCT00200031
Health Authority:	United States: Institutional Review Board

Study placed in the following topic categories:

Signs and Symptoms
Urinary Bladder, Overactive
Cystocele
Urologic Diseases

Urination Disorders
Urinary Bladder Diseases
Quality of Life
Urinary Retention

Additional relevant MeSH terms:

Urological Manifestations

ClinicalTrials.gov processed this record on January 16, 2009